ACET – adicet bio, inc. (US:NASDAQ)

News

Adicet Bio (ACET) was upgraded by Truist Financial Corporation to "strong-buy".
Adicet Bio (ACET) had its price target lowered by HC Wainwright from $50.00 to $27.00. They now have a "buy" rating on the stock.
Adicet Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress
Adicet Bio to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 [Yahoo! Finance]
Adicet Bio to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com